BRNS
Barinthus Biotherapeutics
BRNS
BRNS
13 hedge funds and large institutions have $21.6M invested in Barinthus Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
13
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$195K | |
| 2 | +$128K | |
| 3 | +$26K | |
| 4 |
IIM
Ipswich Investment Management
Beverly,
Massachusetts
|
+$12.8K |
| 5 |
Millennium Management
New York
|
+$3.49K |
Top Sellers
| 1 | -$323K | |
| 2 | -$41.5K | |
| 3 | -$39.8K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8.81K |